US4137327A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for weight reduction
Assignee: Individual
•
Filing: 1974-05-09
•
Granted: 1979-01-30
•
Expires: 1994-05-09
Abstract
Abstract In the digestive tract certain nerve endings regulate the release of certain hormones in response to the movement of a quantity of food through the digestive tract. This release of hormones controls the operation of the pancreas in supplying to the intestinal tract certain digestive enzymes which are used in breaking down fats, proteins, and certain complex carbohydrates in the food as the quantity of food passes through the small intestine. It is possible to anesthesize these nerve endings prior to the consumption of such a quantity of food so as to inhibit the release of these hormones. As a consequence of this, a quantity of food moving through the digestive tract past these anesthesized nerve endings will not be subject to the action of these enzymes and will move through the small intestine without such types of materials contributing food energy or calories to the body. This can be utilized to accomplish a reduction in weight or to control weight.
Inventors
- 👤 Edward M. Marshall
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 04:11
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/16; A61K31/165
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
222 words
In a weight control process in which a quantity of food is consumed and passes through the gastro intestinal digestive tract of a living body: said quantity of food including foodstuffs requiring digestion caused by pancreatic enzymes for absorption into the bloodstream from the small intestine, the improvement which comprises periodically anesthesizing the nerve endings in the digestive tract which release hormones when contacted by food passing through the digestive tract so as to trigger the release of said pancreatic enzymes into the digestive tract by the pancreas prior to said quantity of food contacting said nerve endings only prior to the passage of food into said digestive tract, said anesthetization being carried out to an extent effective and at a time effective to inhibit said nerve endings from releasing sufficient hormones to cause the release of said pancreatic enzymes which will contact said food as it passes through the digestive tract, said anesthetization serving to prevent the release of said hormones when said nerve endings are contacted by said quantity of food, this having the effect of preventing release of said enzymes by the pancreas to the digestive tract so that said food passes through the digestive tract without being digested so that it is capable of being absorbed into the bloodstream as a consequence of the absence of said enzymes
Claim 2
Dependent Claim
222 words
In a weight control process in which a quantity of food is consumed and passes through the gastro intestinal digestive tract of a living body: said quantity of food including foodstuffs requiring digestion caused by pancreatic enzymes for absorption into the bloodstream from the small intestine, the improvement which comprises periodically anesthesizing the nerve endings in the digestive tract which release hormones when contacted by food passing through the digestive tract so as to trigger the release of said pancreatic enzymes into the digestive tract by the pancreas prior to said quantity of food contacting said nerve endings only prior to the passage of food into said digestive tract, said anesthetization being carried out to an extent effective and at a time effective to inhibit said nerve endings from releasing sufficient hormones to cause the release of said pancreatic enzymes which will contact said food as it passes through the digestive tract, said anesthetization serving to prevent the release of said hormones when said nerve endings are contacted by said quantity of food, this having the effect of preventing release of said enzymes by the pancreas to the digestive tract so that said food passes through the digestive tract without being digested so that it is capable of being absorbed into the bloodstream as a consequence of the absence of said enzymes
Claim 3
Dependent Claim
60 words
A weight control process as claimed in claim 1 wherein: said nerve endings are anesthesized by orally taking a quantity effective to cause said inhibition of an anesthetic means coated with a coating means which is effective to delay the release of said anesthetic means until said anesthetic means reaches the vicinity of said nerve endings in the digestive tract.
Claim 4
Dependent Claim
15 words
A weight control process as claimed in claim 2 wherein: said anesthetic means is oxethazaine.
Claim 5
Dependent Claim
34 words
A weight control process as claimed in claim 2 wherein: said anesthetic means is orally taken with an adherence means for causing said anesthetic means to adhere to the interior of the digestive tract.
Claim 6
Dependent Claim
35 words
A weight control process as claimed in claim 4 wherein: said adherence means is albumin and is admixed with said anesthetic means, said anesthetic means and said albumin both being coated with said coating means.
Claim 7
Dependent Claim
38 words
A weight control process as claimed in claim 2 wherein: from about 50 to about 2,000 milligrams of said anesthetic means are taken at one time, said time being prior to food being taken into the digestive tract.
Claim 8
Dependent Claim
38 words
A weight control process as claimed in claim 2 wherein: from about 200 to about 800 milligrams of said anesthetic means are taken at one time, said time being prior to food being taken into the digestive tract.
Claim 9
Dependent Claim
91 words
A weight control process as claimed in claim 1 wherein: said nerve endings are anesthesied by orally taking a quantity effective to cause said inhibition of an anesthetic means coated with a coating which will delay the release of said anesthetic means until said anesthetic means reaches the vicinity of said nerve endings in the digestive tract, said anesthetic means is oxethazaine, and from about 50 to about 2,000 milligrams of said anesthetic means are taken at one time, said time being prior to food being taken into the digestive tract.
Claim 10
Dependent Claim
55 words
A weight control process as claimed in claim 8 wherein: said anesthetic means is orally taken with adherence means for causing said anesthetic to adhere to the interior of the digestive tract, and said adherence means is albumin and is admixed with said anesthetic, said anesthetic and said albumin both being coated with said coating.
References Cited (Backward Citations)
US3740440A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-01-29 | 1982-07-31 | 1983-01-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-01-29 | 1986-07-31 | 1987-01-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-01-29 | 1990-07-31 | 1991-01-30 | $7700.00 | Window Closed / Lapsed |